- Home
- KNSA vs ATR Comparison
KNSA vs ATR Comparison
Compare KNSA & ATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KNSA | ATR |
|---|---|---|
| Founded | 2015 | 1992 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Plastic Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7B | 8.0B |
| IPO Year | 2018 | 1995 |
Fundamental Metrics
Financial Performance| Metric | KNSA | ATR |
|---|---|---|
| Price | $94.47 | $142.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | $109.43 | ★ $163.88 |
| AVG Volume (30 Days) | ★ 925.9K | 507.9K |
| Earning Date | 10-27-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 1.39% |
| EPS Growth | ★ 225.00 | 6.51 |
| EPS | 1.14 | ★ 3.00 |
| Revenue | $677,564,000.00 | ★ $3,777,181,000.00 |
| Revenue This Year | $54.96 | $6.23 |
| Revenue Next Year | $24.16 | $3.55 |
| P/E Ratio | $84.32 | ★ $48.82 |
| Revenue Growth | ★ 60.09 | 5.42 |
| 52 Week Low | $37.02 | $110.95 |
| 52 Week High | $98.48 | $147.21 |
Technical Indicators
Market Signals| Indicator | KNSA | ATR |
|---|---|---|
| Relative Strength Index (RSI) | 60.03 | 68.20 |
| Support Level | $72.76 | $120.22 |
| Resistance Level | $98.48 | $146.24 |
| Average True Range (ATR) | 5.49 | 3.54 |
| MACD | 0.78 | 1.90 |
| Stochastic Oscillator | 84.57 | 71.09 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About ATR AptarGroup Inc.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.